RA CAPITAL MANAGEMENT, L.P.
86 holdingsFiling period: 2026-03-31Current AUM: $10.10Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ASND | ASCENDIS PHARMA A/S - ADR | 10.28M | $2.35B | $2.51B | 24.84% | -- | 2026-03-31 |
| 2 | PCVX | VAXCYTE INC | 11.47M | $666.8M | $620.5M | 6.15% | +750.0K | 2026-03-31 |
| 3 | RYTM | RHYTHM PHARMACEUTICALS INC | 6.67M | $579.8M | $661.7M | 6.55% | -- | 2026-03-31 |
| 4 | TYRA | TYRA BIOSCIENCES INC | 12.20M | $467.2M | $388.9M | 3.85% | -- | 2026-03-31 |
| 5 | SION | SIONNA THERAPEUTICS INC | 9.91M | $397.1M | $466.8M | 4.62% | -- | 2026-03-31 |
| 6 | EWTX | EDGEWISE THERAPEUTICS INC | 10.43M | $328.5M | $400.8M | 3.97% | -- | 2026-03-31 |
| 7 | — | NEWAMSTERDAM PHARMA CO NV | 9.55M | $305.7M | $305.7M | 3.03% | -- | 2026-03-31 |
| 8 | NUVL | NUVALENT INC-A | 2.53M | $259.6M | $259.6M | 2.57% | +654.1K | 2026-03-31 |
| 9 | DNTH | DIANTHUS THERAPEUTICS INC | 2.61M | $219.2M | $279.2M | 2.77% | +1.00M | 2026-03-31 |
| 10 | MLYS | MINERALYS THERAPEUTICS INC | 7.69M | $208.4M | $196.3M | 1.94% | +369.0K | 2026-03-31 |
| 11 | SGP | SPYGLASS PHARMA INC | 8.02M | $207.8M | $180.7M | 1.79% | -- | 2026-03-31 |
| 12 | — | WAVE LIFE SCIENCES LTD | 26.98M | $195.6M | $195.6M | 1.94% | +8.77M | 2026-03-31 |
| 13 | SEPN | SEPTERNA INC | 7.00M | $168.1M | $241.0M | 2.39% | -- | 2026-03-31 |
| 14 | IRON | DISC MEDICINE INC | 2.45M | $156.7M | $188.7M | 1.87% | +474.1K | 2026-03-31 |
| 15 | JANX | JANUX THERAPEUTICS INC | 11.19M | $155.5M | $169.7M | 1.68% | -- | 2026-03-31 |
| 16 | BCRX | BIOCRYST PHARMACEUTICALS INC | 15.83M | $150.7M | $142.1M | 1.41% | -- | 2026-03-31 |
| 17 | BCAX | BICARA THERAPEUTICS INC | 7.26M | $144.3M | $196.6M | 1.95% | +300.0K | 2026-03-31 |
| 18 | PRAX | PRAXIS PRECISION MEDICINES I | 373.8K | $120.4M | $115.1M | 1.14% | -- | 2026-03-31 |
| 19 | — | GH RESEARCH PLC | 7.68M | $107.9M | $107.9M | 1.07% | -- | 2026-03-31 |
| 20 | ZLAB | ZAI LAB LTD-ADR | 5.71M | $107.4M | $104.3M | 1.03% | -- | 2026-03-31 |
| 21 | TSHA | TAYSHA GENE THERAPIES INC | 23.56M | $105.3M | $138.0M | 1.37% | -- | 2026-03-31 |
| 22 | VOR | VOR BIOPHARMA INC | 5.40M | $96.4M | $114.3M | 1.13% | -- | 2026-03-31 |
| 23 | GERN | GERON CORP | 63.77M | $95.0M | $82.3M | 0.81% | -- | 2026-03-31 |
| 24 | SPRY | ARS PHARMACEUTICALS INC | 10.86M | $87.2M | $55.7M | 0.55% | -- | 2026-03-31 |
| 25 | SRPT | SAREPTA THERAPEUTICS INC | 3.90M | $84.9M | $58.0M | 0.57% | -- | 2026-03-31 |
← Scroll →
Page 1 of 4